English
FranįaisObbligazione Royalty Pharma 5.95% ( US78081BAV53 ) in USD
| Emittente | Royalty Pharma | ||||
| Prezzo di mercato |  100.00 USD ▲ |
||||
| Paese |  Stati Uniti
|
||||
| Codice isin |
 US78081BAV53 ( in USD )
|
||||
| Tasso d'interesse | 5.95% per anno ( pagato 2 volte l'anno) | ||||
| Scadenza | 25/09/2055 | ||||
|
La brochure del prospetto in formato PDF |
|||||
| Importo minimo | / | ||||
| Importo totale | / | ||||
| Cusip | 78081BAV5 | ||||
| Standard & Poor's ( S&P ) rating | BBB ( Lower medium grade - Investment-grade ) | ||||
| Moody's rating | Baa2 ( Lower medium grade - Investment-grade ) | ||||
| Coupon successivo | 25/09/2026 ( In 9 giorni ) | ||||
| Descrizione dettagliata |
Royalty Pharma č una societā di investimento biofarmaceutico che acquista diritti di royalty su farmaci giā approvati. The Obbligazione issued by Royalty Pharma ( United States ) , in USD, with the ISIN code US78081BAV53, pays a coupon of 5.95% per year. The coupons are paid 2 times per year and the Obbligazione maturity is 25/09/2055 The Obbligazione issued by Royalty Pharma ( United States ) , in USD, with the ISIN code US78081BAV53, was rated Baa2 ( Lower medium grade - Investment-grade ) by Moody's credit rating agency. The Obbligazione issued by Royalty Pharma ( United States ) , in USD, with the ISIN code US78081BAV53, was rated BBB ( Lower medium grade - Investment-grade ) by Standard & Poor's ( S&P ) credit rating agency. |
||||
| |||||